What Is/Nonprofit Organization/Plano/Researching Type 1 Diabetes
Type 1 diabetes is an auto-immune condition in which the immune system is activated to destroy the cells in the pancreas which produce insulin. We do not know what causes this auto-immune reaction. Type 1 diabetes is not linked to modifiable lifestyle factors. There is no cure and it cannot be prevented.
Type 1 diabetes:
– Occurs when the pancreas does not produce insulin
– Represents around 10% of all cases of diabetes and is one of the most common chronic childhood conditions
– Onset is usually abrupt and the symptoms obvious
– Symptoms can include excessive thirst and urination, unexplained weight loss, weakness and fatigue and blurred vision
– Is managed with insulin injections several times a day or the use of an insulin pump.
The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services Plano city, Collin and Denton counties, northern Texas, U.S., located about 16 miles (26 km) northeast of Dallas. It is situated in a region of blackland prairie and was first settled (1845–46) by a group called Peters’ Colony (named for William S. Peters, who had led investors in gaining land grants from the Republic of Texas in the early 1840s). The community was granted a post office in 1851; several names were proposed, and ultimately Plano—which a leading citizen understood to be the Spanish word meaning “plain,” an apt description of the terrain—was selected. The railroad reached Plano in 1872, and, although the town was almost destroyed by fire in 1881, it continued to develop as a small agricultural centre in the midst of a cotton-producing and cattle-raising area. Plano’s rapid population growth began in the 1960s, when the population was less than 4,000, a result of the expansion of the Dallas–Fort Worth area. JDRF is the world’s leading charitable funder of type 1 diabetes research and raise money to drive world class research. We aim to find new ways to treat type 1 diabetes and its complications, prevent type 1 from developing and find the cure for people who already have the condition.
JDRF’s research mission is to discover, develop, and deliver advances that cure, better treat, and prevent T1D. As the global leader in the fight against T1D, JDRF’s research programs are comprehensive – addressing the hopes and dreams of every person with T1D for the best quality of life and a cure for this disease.
Millions of people around the world live with type 1 diabetes (T1D), a life-threatening autoimmune disease that strikes both children and adults. There is no way to prevent it, and at present, no cure. JDRF works every day to change this by amassing grassroots support, deep scientific knowledge and strong industry and academic partnerships to fund research. Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/42334 JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To draw the conclusion, let’s identify the main points –
Glucose,Research Grants,antihyperglycemic agents,diabetes management,Kidney Disease,Gymnastic Capital of the World,take action,diabetes diagnosis,75-g oral glucose tolerance test,Diabetes Complications,Type 1 Diabetes,T1D Progression,ACCORD Study,take action,estimated average glucose,engage,First time with insulin pump,Bolus insulin,IDDP program,Children’s Congress,blood pressure,Clinical Trials,grassroots fundraising,T1D Mentors,undiagnosed diabetes,Insulin detemir,care delivery systems,Abstracts of JDRF Research,lente insulin,symptoms of T1D,HAPO Study,Nutrition,ultralente insulin,World without T1D,Non-Profit Organization,EsTiD,hyperosmolar hyperglycemic nonketotic syndrome,50/50 insulin,insulin body site rotation,life-changing breakthroughs,T1D community,Pancreas,Continuous glucose monitoring,Regular Acting Insulin,T1D Team,donate to help,diabetes.